Drug–disease association prediction with literature based multi-feature fusion
Frontiers in Pharmacology · 22.05.2023 · 14
DOI: 10.3389/fphar.2023.1205144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.05.2023. Verfasst von Hongyu Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Social Science Fund of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Introduction
Exploring the potential efficacy of a drug is a valid approach for drug development with shorter development times and lower costs. Recently, several computational drug repositioning methods have been introduced to learn multi-features for potential association prediction. However, fully leveraging the vast amount of information in the scientific literature to enhance drug-disease association prediction is a great challenge.
Methods
We constructed a drug-disease association prediction method called Literature Based Multi-Feature Fusion (LBMFF), which effectively integrated known drugs, diseases, side effects and target associations from public databases as well as literature semantic features. Specifically, a pre-training and fine-tuning BERT model was introduced to extract literature semantic information for similarity assessment. Then, we revealed drug and disease embeddings from the constructed fusion similarity matrix by a graph convolutional network with an attention mechanism.
Results
LBMFF achieved superior performance in drug-disease association prediction with an AUC value of 0.8818 and an AUPR value of 0.5916.
Discussion
LBMFF achieved relative improvements of 31.67% and 16.09%, respectively, over the second-best results, compared to single feature methods and seven existing state-of-the-art prediction methods on the same test datasets. Meanwhile, case studies have verified that LBMFF can discover new associations to accelerate drug development. The proposed benchmark dataset and source code are available at: https://github.com/kang-hongyu/LBMFF .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China.
- Institute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- National Social Science Fund of China
- National Key Research and Development Program of China
Zitieren
APA
Kang, H., Hou, L., Gu, Y., Lu, X., Li, J., & Li, Q. (2023). Drug–disease association prediction with literature based multi-feature fusion. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1205144
Vancouver
Kang H, Hou L, Gu Y, Lu X, Li J, Li Q. Drug–disease association prediction with literature based multi-feature fusion. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1205144
BibTeX
@article{Kang2023,
author = {Kang, Hongyu and Hou, Li and Gu, Yaowen and Lu, Xiao and Li, Jiao and Li, Qin},
title = {Drug–disease association prediction with literature based multi-feature fusion},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1205144}
}
EUVIMED